Safety and Efficacy of VDPHL01 in Males and Females With AGA
Active, not recruitingNCT06527365
Veradermics, Inc.AGA, Androgenetic Alopecia, Male Pattern Baldness
Start: 2024-07-08End: 2026-08-31Target: 70Updated: 2025-11-06
Efficacy and Safety of VDPHL01 in Males With AGA
Active, not recruitingNCT06724614
Veradermics, Inc.AGA, Androgenetic Alopecia, Male Pattern Baldness
Start: 2024-11-06End: 2026-09-30Target: 480Updated: 2025-11-06